Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Sexually experienced, but not naïve, female rats show a conditioned object preference (COP) for mating after a single training trial.

Piergies AMH, Hicks ME Jr, Schwartz JP, Meerts SH.

Physiol Behav. 2019 Jan 1;198:42-47. doi: 10.1016/j.physbeh.2018.09.017. Epub 2018 Oct 2.

PMID:
30290181
2.

Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.

Findling RL, Nucci G, Piergies AA, Gomeni R, Bartolic EI, Fong R, Carpenter DJ, Leeder JS, Gaedigk A, Danoff TM.

Neuropsychopharmacology. 2006 Jun;31(6):1274-85.

3.

Comparative efficacy of new investigational agents against Helicobacter pylori.

Osato MS, Reddy SG, Piergies AA, Bochenek WJ, Testa RT, Graham DY.

Aliment Pharmacol Ther. 2001 Apr;15(4):487-92.

4.

Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.

Karim A, Tolbert D, Piergies A, Hubbard RC, Harper K, Wallemark CB, Slater M, Geis GS.

J Clin Pharmacol. 2000 Jun;40(6):655-63.

PMID:
10868317
5.

Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.

Paulson SK, Hribar JD, Liu NW, Hajdu E, Bible RH Jr, Piergies A, Karim A.

Drug Metab Dispos. 2000 Mar;28(3):308-14.

PMID:
10681375
6.

Assessment of coagulation system activation using spot urine measurements.

Lind SE, Goldshteyn S, Barry CP, Lindquist JR, Piergies AA, Rosen T, Schneider JR, Shevrin DH, Caprini JA.

Blood Coagul Fibrinolysis. 1999 Jul;10(5):285-9.

PMID:
10456620
7.

Pharmacokinetic interaction between ritonavir and didanosine when administered concurrently to HIV-infected patients.

Cato A 3rd, Qian J, Hsu A, Vomvouras S, Piergies AA, Leonard J, Granneman R.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):466-72.

PMID:
9715843
8.

Pharmacokinetic study of the interaction between rifabutin and delavirdine mesylate in HIV-1 infected patients.

Borin MT, Chambers JH, Carel BJ, Freimuth WW, Aksentijevich S, Piergies AA.

Antiviral Res. 1997 Jun;35(1):53-63.

PMID:
9224961
9.

Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens.

Piergies AA, Sainati S, Roth-Schechter B.

Arch Pathol Lab Med. 1997 Apr;121(4):392-4.

PMID:
9140309
10.

The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.

Piergies AA, Sweet J, Johnson M, Roth-Schechter BF, Allard S.

Int J Clin Pharmacol Ther. 1996 Apr;34(4):178-83.

PMID:
8861737
11.

Clinical pharmacology and first-time-in-man studies: the FDA levels the playing field.

Luderer J, Piergies AA, Jorkasky D, Sedman A, Reele S, Froehlich J, Cavanaugh J, Steinman GL.

J Clin Pharmacol. 1996 Mar;36(3):187-8. No abstract available.

PMID:
8690810
12.
13.

Pharmacokinetics of tacrolimus in liver transplant patients.

Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, Mekki QA.

Clin Pharmacol Ther. 1995 Mar;57(3):281-90.

PMID:
7535213
14.

Pharmacokinetics and acute cardiovascular effects of menogaril in patients with metastatic tumors.

Piergies AA, Benson AB 3rd.

Int J Clin Pharmacol Ther. 1995 Feb;33(2):63-9.

PMID:
7757312
15.

A concurrent audit of high digoxin plasma levels.

Piergies AA, Worwag EM, Atkinson AJ Jr.

Clin Pharmacol Ther. 1994 Mar;55(3):353-8.

PMID:
8143400
16.

Activation of renin-angiotensin system does not cause skeletal muscle cramps during hemodialysis.

Piergies AA, Atkinson AJ Jr, Hubler GL, del Greco F.

Int J Clin Pharmacol Ther Toxicol. 1990 Oct;28(10):405-9.

PMID:
2258248
17.

Pharmacokinetics of N-acetylprocainamide in patients profiled with a stable isotope method.

Atkinson AJ Jr, Ruo TI, Piergies AA, Breiter HC, Connelly TJ, Sedek GS, Juan D, Hubler GL, Hsieh AM.

Clin Pharmacol Ther. 1989 Aug;46(2):182-9.

PMID:
2474402
18.

Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.

Atkinson AJ Jr, Ruo TI, Piergies AA.

Angiology. 1988 Jul;39(7 Pt 2):655-67. Review.

PMID:
2457345
19.

Effect kinetics of N-acetylprocainamide-induced QT interval prolongation.

Piergies AA, Ruo TI, Jansyn EM, Belknap SM, Atkinson AJ Jr.

Clin Pharmacol Ther. 1987 Jul;42(1):107-12.

PMID:
2439251
20.

Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.

Rosen ST, Zimmer AM, Goldman-Leikin R, Gordon LI, Kazikiewicz JM, Kaplan EH, Variakojis D, Marder RJ, Dykewicz MS, Piergies A, et al.

J Clin Oncol. 1987 Apr;5(4):562-73.

PMID:
3549989
21.

An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.

Löffler L, Bauernfeind A, Keyl W, Hoffstedt B, Piergies A, Lenz W.

Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S593-8.

PMID:
3026009
22.

Torsade de pointes induced by N-acetylprocainamide.

Chow MJ, Piergies AA, Bowsher DJ, Murphy JJ, Kushner W, Ruo TI, Asada A, Talano JV, Atkinson AJ Jr.

J Am Coll Cardiol. 1984 Sep;4(3):621-4.

23.

[Field trial with a new betablocker (Solgol)].

Piergies A, Schimert G.

MMW Munch Med Wochenschr. 1980 Oct 17;122(42):1473-6. German.

PMID:
6110182
24.

[Fluphenazine dihydrochloride--a multicenter trial on 660 patients (author's transl)].

Pieschl D, Kulhanek F, Piergies A.

Arzneimittelforschung. 1978;28(9):1503-4. German.

PMID:
383100

Supplemental Content

Loading ...
Support Center